CPD On-Line
CPD On-Line
Hartley Taylor are working to bring you CPD education and now have presentations for you to review with points awarded for CPD accreditation. We will focus on many disease areas, conferences that will be virtual as updates, and bring you valuable information on new products entering the UK market.

South West Acute Leukaemia Forum – 9th February 2022:
1 CPD point
More Details
Tagresofusp, BPDCN and its management
Naveen Pemmaraju, MD Anderson, USA
Presentation during the South West Acute Leukaemia Forum – 9th February 2022
Registration is free of charge

South West Lymphoma Group – 30th March 2022
1 CPD Point
More Details
Satellite Symposium – Sponsored by Novartis
Real World Experience with CAR-T cell therapy
Dr Annalisa Chiappella, IRCCS National Cancer Institute Foundation, Milan

South West Lymphoma Group – Cutaneous Lymphoma Workshop – 30th March 2022
1 CPD Point
More Details
Treatment options in mycosis fungoides and Sézary syndrome – tailoring to your patients
Dr Kevin Molloy, Dublin
Supported by educational grant from Kyowa Kirin

Myeloproliferative Post ASH Highlights – 26th January 2022
2 CPD Points
More Details
Myeloproliferative neoplasms
Mary Frances McMullin, Belfast
Blast phase MPN
Adam Mead, Oxford
Chronic myeloid leukaemia
Hugues de Lavallade, London
Rare MPN, systemic mastocytosis, eosinophilia and CNL
Deepti Radia, London

3rd NCRI AML Academy
Management of Adult AML: where are we in 2021?
3 CPD Points
More Details
Topics:
How does genomics and MRD guide transplant decision making (Dr Rachel Protheroe, Bristol)
Application of genomics in routine clinical practice: cases for roundtable discussion
Panel with cases: Professor David Bowen, Leeds, Dr Rachel Protheroe, Bristol and Dr Priyanka Mehta, Bristol
Venetoclax – a pragmatic approach – Cases (Dr Mike Dennis, Manchester & Dr Erin Hurst, Newcastle)
Supportive Care Roundtable Workshop:
COVID immunisation strategy for AML patients Dr Justin Loke, Birmingham
Microbiome (Dr David Lowe, London)
High volume v low volume centres (Professor David Bowen, Leeds)
Management of high risk AML – the role of transplant stratification in older fit adults with AML (Professor Guido Kobbe, Düsseldorf)
Debate: Venetoclax-based induction regimens can now be considered as standard of care for the majority of adults over the age of 60 with newly-diagnosed AML
Proposers: Dr Lynn Quek, London & Dr David Taussig, London
Opposer: Dr Sudhir Tauro, Dundee

Emerging Options in the Treatment of Waldenstrom’s Macroglobulinemia: 2 CPD points
Supported by an unrestricted educational grant from BeiGene
More Details
Topics:
1st line treatments – current recommendations and guidelines (Rebecca Auer, Barts London)
Debate: The role of SCT in the younger patient For: Shirley D’Sa, UCLH, Against: Roger Owen, Leeds
IgM related disorders – peripheral neuropathy (Prof Michael Lunn, Neurologist, Queen Square, London)
Managing BTKIs and toxicities (Jam Kothari, Oxford)
Mutational analysis – latest thinking in the science (Roger Owen, Leeds)

Immunomodulation Updates: Advances in a COVID Era: 5 CPD points
Supported by an unrestricted educational grant from Mallinckrodt
More Details
This day will include lectures and panel discussions from UK and international experts on topics such as keeping services going during COVID, chronic GVHD, dermatology, a ‘difficult cases’ MDT panel
Keeping services going during Covid
James Griffin, Apheresis and ECP audits – reassuring patients
Piers Patten, Covid-19 and Haemato-Oncology – where are we?
Fiona Dignan & Maria Waller, The patient experience during COVID
Chronic GVHD
Francesca Kinsella, UKPS audit data for ECP in chronic GVHD
Harpreet Kaur, Signaling pathways and long term management for chronic GVHD
Nicolaus Kroger, New agents & sequencing treatment for GVHD: when to stop, start, add in or change
Panel discussion
Dermatology review and an MDT review of difficult cases
Dr Arun Alfred, Neurological manifestations of GVHD
Dr Victoria Potter patient including gut GVHD
Registration is free

Myeloproliferative Neoplasms Advances Day: 7 CPD points
More Details
COVID outcomes and MPN: what do we know
Professor Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, Italy
Genetics and myeloid diagnostics: latest UK guidance
Professor Nick Cross, University of Southampton
Challenges of triple negative thrombocytosis
Dr Rebecca Frewin, Gloucestershire Hospitals
MPNU
Dr Donal McLornan, GSTT & UCLH and Dr Rupen Hargreaves, UCLH
Mastocytosis update
Dr Deepti Radia, Guy’s and St Thomas’ NHS Foundation Trust
CML challenges
Dr Hugues de Lavallade, Guy’s and St Thomas’ NHS Foundation Trust
CMML: how to treat in 2021
Dr Dan Wiseman, The Christie NHS Foundation Trust, Manchester
MDS/AA overlap disorders
Dr Austin Kulasekararaj, King’s College Hospital
Progress with mutCALR vaccine
Professor Morten Holstrom, Herlev University Hospital, Denmark
Interferon for MPN in 2021
Professor Jean Jacques Kiladjian, Hopital St Louis, Paris
Management of accelerated and blast phase MPN
Professor Serge Verstovsek, MD Anderson Cancer Center, Houston
Is disease modification in myelofibrosis an achievable goal?
Professor Adam Mead, University of Oxford
Polycythaemia vera advances and future options
Professor Mary Frances McMullin, Queen’s University Belfast
Current and future landscapes for ET therapy
Dr Anna Godfrey, Cambridge University Hospitals
Registration is free of charge

CAR-T Nursing & Allied Healthcare Professionals: Challenges and Considerations: 6 CPD points
More Details
The science of CAR-T Dr Elaine Vickers – improving our knowledge Founder of Science Communicated Ltd
Demystifying the patient pathway Genevieve French, CAR-T CNS, King’s College Hospital
UK patient data Dr Andrea Kuhnl, Consultant Haematologist, King’s College Hospital
Palliative care and CAR-T: an integrated approach Maria Mazza-Beange, University Hospitals Bristol
AHP pathways in CAR-T Interviewer: Órla Stewart, Lead Nurse, King’s College Hospital, Aimee Green, Band 7 Physiotherapist CAR-T/Haematology, The Christie, Manchester, Hannah Winn, Senior Specialist Oncology Dietician, The Christie, Manchester
Managing toxicities: case reviews Rose Ellard, Royal Marsden Hospital
Long term follow-up in the CAR-T patient population Órla Stewart, King’s College Hospital
Patient Perspectives: Interview from Manchester Sophie Mulligan, Patient, Rita Angelica, CNS, The Christie, Manchester
Panel discussion: Órla Stewart, Rose Ellard, Sophie Mulligan, Rita Angelica
Addressing the psychological needs of the CAR-T patient Dr Justin Grayer, Consultant Psychologist and
Psychosexual Therapist, Lead for Adult Psychological Support, Royal Marsden Hospital
Patient Perspectives: Interview from Bristol Kenneth Nottage, Patient Maria Mazza-Beange, University Hospitals Bristol
Insights from an Expert Panel: Órla Stewart, Rose Ellard, Maria Mazza-Beange, Andrea Kuhnl
Registration is free of charge

Experts in Haematology – Online Faculty Meeting – October 2021: 2 CPD points
Thrombocytopenic and Thrombosis Challenges
More Details
HITT + VITT
Dr Will Lester, Queen Elizabeth Hospital
Laboratory testing for VITT and monitoring of Argatroban and Fondaparinux
Dr Steve Kitchen, Sheffield Haemophilia and Thrombosis Centre
Thrombocytopenic thrombosis – ITP
Dr Gary Benson, Belfast Health and Social Care Trust
Thrombocytopenic thrombosis – TTP & DIC
Dr Jecko Thachil, Manchester Royal Infirmary
An educational resource from Grifols
Registration is free of charge

HMDS Updates: Myeloma – 2 CPD points
Highlights from the HMDS Annual Haematopathology Update Day – 8th September 2021
More Details
Clinical update – update from myeloma trials
Dr Charlotte Pawlyn, Institute of Cancer Research, London
Sequential MRD monitoring in myeloma
Dr Ruth de Tute, HMDS, Leeds
Cellular therapies in myeloma
Dr Frances Seymour, Leeds Teaching Hospitals
Panel discussion
Registration is free of charge

HMDS Updates: Lymphoma – 2 CPD points
Highlights from the HMDS Annual Haematopathology Update Day – 8th September 2021
More Details
Overview and role of bi-specific antibodies
Dr Will Townsend, UCLH, London
Molecular analysis and classification of lymphoid malignancies
Dr Sharon Barrans, Leeds Teaching Hospitals
Molecular subclusters of follicular lymphoma
Professor Reuben Tooze, HMDS & University of Leeds
Panel discussion
Registration is free of charge

HMDS Updates: Genomics and Rarer MPN – 2 CPD points
Highlights from the HMDS Annual Haematopathology Update Day – 8th September 2021
More Details
Single high-throughput sequencing panel for use in all haematological malignancies: Leeds HMDS experience
Dr Paul Evans, HMDS, Leeds
Eosinophilia – an update
Professor Nick Cross, University of Southampton
Myeloproliferative neoplasms
Dr Adam Mead, Oxford University Hospitals
Registration is free of charge

Current Thinking in Haematological Malignancies
Challenges and Recurring Themes at MDT …. a case-based MDT meeting: 6 CPD points
Register to watch this comprehensive update in Haematological Malignancies from the practical perspective of an MDT
More Details
This meeting was designed to address the challenges and recurring themes faced by the MDT. Sessions are highly interactive with experts reviewing complex cases and sharing latest data on treatments.
Enjoy the following sessions:
Myeloma: Elderly and relapse
Professor Graham Jackson (Newcastle) and Dr Chris Parrish (Leeds)
Chronic Leukaemia: MDM management dilemmas with front line, relapse and ultra-high risk CLL patients
Dr Piers Patten (London), Dr Helen Marr (Newcastle) and Dr Anne Parker (Glasgow)
AML: Newly diagnosed and who to transplant
Dr Mike Dennis (Manchester), Dr Annie Latif (Glasgow) and Dr Rachel Protheroe (Bristol)
Lymphoma Carousel: MCL CAR T when?, bispecifics when? …and some challenging T cell cases
Prof Tim Illidge (Manchester), Dr Wendy Osborne (Newcastle), Dr Tobias Menne (Newcastle) & Dr Piers Patten (London)
ALL: Hot topics everyone should know & how young is young?
Dr Tobias Menne (Newcastle) and Dr Anna Castleton (Manchester)
MDT Panel: When is allograft appropriate – disease specific discussions
Dr Anne Parker (Glasgow), Dr Wendy Osborne (Newcastle), Prof Graham Jackson (Newcastle), Dr Tobias Menne (Newcastle) and Dr Fiona Dignan (Manchester)
Registration Fee: £60 (£50 + VAT)

ITP in a COVID era
Dr Nichola Cooper and Dr Christine O Ademokun
More Details
An educational resource to accompany the ITP Update Day on Friday 14th May
Registration is free of charge

Prevention and management of complications in transplant – Late effects and long-term survivorship: 1 CPD point
Highlight from the Post EBMT Update Day – 21st April 2021
More Details
Prevention and management of complications in transplant
Late effects and long-term survivorship
Professor Navneet Majhail, Cleveland Clinic, USA
Registration is free of charge

Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF